Biondo Investment Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$5.52M |
| 2 |
VF Corp
VFC
|
+$4.54M |
| 3 |
Edwards Lifesciences
EW
|
+$3.88M |
| 4 |
Intuitive Surgical
ISRG
|
+$1.86M |
| 5 |
Zoetis
ZTS
|
+$1.52M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$3.33M |
| 2 |
Altria Group
MO
|
+$2.91M |
| 3 |
HDV
iShares Core High Dividend ETF
HDV
|
+$587K |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$252K |
| 5 |
Illumina
ILMN
|
+$96.8K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.15% |
| 2 | Technology | 24.33% |
| 3 | Financials | 9.78% |
| 4 | Consumer Discretionary | 9.46% |
| 5 | Communication Services | 4.8% |
Similar funds
Biondo Investment Advisors's Q3 2020 Portfolio in Review
As of Q3 2020, Biondo Investment Advisors held 85 positions worth $461M, up 16% from $396M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Biondo Investment Advisors deployed $19.7M of net new capital in Q3 2020, opening 8 new positions and adding to 60 existing holdings. Its largest new stake was ExxonMobil: 134,943 shares worth $4.63M.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 38% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares Core High Dividend ETF, an estimated $587K trimmed.
- Biondo Investment Advisors's largest Q3 2020 buy was ExxonMobil: 134,943 shares worth $4.63M.
- Biondo Investment Advisors added most to Edwards Lifesciences in Q3 2020, an estimated $3.88M increase.
- Biondo Investment Advisors's biggest Q3 2020 reduction was iShares Core High Dividend ETF, cutting an estimated $587K.
- Biondo Investment Advisors fully exited AT&T in Q3 2020, selling an estimated $3.33M.
- Biondo Investment Advisors's ten largest holdings make up 50% of its $461M portfolio in Q3 2020.
- Biondo Investment Advisors opened 8 new positions and closed 2 in Q3 2020.
- Biondo Investment Advisors's portfolio value rose 16% quarter-over-quarter to $461M.
Based on Biondo Investment Advisors's 13F filing for Q3 2020, filed 5 Nov 2020.